Seeking Alpha

  Sevion Therapeutics, Inc. - OTCQB

11/24/2014, 3:02 PM ET
  • Chemistfrog | Send Message 14 Jan

    Interview With Fabrus President Dr. Vaugh Smider $SVON
    Reply (2)
    • petethepanzer | Send Message 14 Jan
      : with snti your buying half a share since you only own 50% of each company with each share is this is good for topline data
    • 146 | Send Message 15 Jan
      : 1 divided by 2 is not absolutely .5 depending on synergies. I suspect, presently not enough info is out to determine either way.
      SVON vs. ETF Alternatives
      Company Description
      The primary business of the Company is to utilize our patented and patent-pending technology related to antibody genes, antibody discovery technology, modified cow antibodies, and antibody drug candidates, and certain genes, primarily eukaryotic translation initiation Factor 5A, or Factor 5A,... More
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States